The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

机译：己酮可可碱对慢性肾病患者促红细胞生成素反应性低反应的氧化应激的影响：HERO试验的子研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

: Pentoxifylline has previously been shown to increase haemoglobin levels in patients with chronic kidney disease (CKD) and erythropoietin-stimulating agent (ESA)-hyporesponsive anaemia in the HERO multi-centre double-blind, randomized controlled trial. The present study evaluated the effects of pentoxifylline on oxidative stress in ESA-hyporesponsive CKD patients.

机译：：在HERO多中心双盲，随机对照试验中，己酮可可碱先前已显示可增加患有慢性肾脏病（CKD）和促红细胞生成素刺激剂（ESA）低反应性贫血的患者的血红蛋白水平。本研究评估了己酮可可碱对ESA低反应性CKD患者氧化应激的影响。

著录项

期刊名称 Redox Report : Communications in Free Radical Research
作者
Lei Zhang; Jeff Coombes; Elaine M. Pascoe; Sunil V. Badve; Kim Dalziel; Alan Cass; Philip Clarke; Paolo Ferrari; Stephen P. McDonald; Alicia T. Morrish; Eugenie Pedagogos; Vlado Perkovic; Donna Reidlinger; Anish Scaria; Rowan Walker; Liza A. Vergara; Carmel M. Hawley; David W. Johnson; on behalf of the HERO Study Collaborative Group;
展开▼
作者单位

展开▼
年(卷),期 2016(21),1
年度 2016
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
Anaemia; Chronic kidney disease; Erythropoiesis-stimulating agent; Oxidative stress; Pentoxifylline;

机译：贫血;慢性肾脏病;促红细胞生成剂;氧化应激;己酮可可碱;

相似文献

外文文献
中文文献
专利

1. The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial [J] . Lei Zhang, Jeff Coombes, Elaine M. Pascoe, Redox report: communications in free radical research . 2016,第1期

机译：己酮可可碱对慢性肾病患者促红细胞生成素反应性低反应的氧化应激的影响：HERO试验的子研究
2. A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial [J] . Johnson David W., Pascoe Elaine M., Badve Sunil V., American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2015,第1期

机译：己酮可可碱对贫血的CKD患者促红细胞生成素低反应性的安慰剂对照随机试验：使用奥沙芬比林（HERO）治疗对促红细胞生成素的抵抗性试验
3. A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL [J] . Johnson D. W., Pascoe E., Badve S. V., Nephrology. . 2014,第Suppla4期

机译：对慢性肾病贫血患者红血球生成刺激剂抗性的一种五溴苯酚的随机控制的试验
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Utilization patterns and economic impact of IV iron and erythropoiesis stimulating agents in chronic kidney disease patients: A multi-hospital study [D] . Joshi, Avani D. 2010

机译：慢性肾脏病患者静脉输注铁和促红细胞生成素刺激剂的使用模式和经济影响：一项多院研究
6. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents darbepoetiN alfa (BRIGHTEN Trial) [O] . Hideki Kato, Masaomi Nangaku, Hideki Hirakata, -1

机译：慢性肾病合并肾脏贫血的患者的观察性临床研究的依据和设计：对促红细胞生成促进剂低反应性贫血的阿尔法患者darpropoetiN alfa的肾脏预后（BRIGHTEN试验）
7. The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial [O] . Lei Zhang, Jeff Coombes, Elaine M. Pascoe, 2016

机译：辛氧化术对慢性肾病患者促红细胞兴奋剂促高响应性的氧化胁迫的影响：英雄试验的亚研究

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

摘要

著录项

相似文献

相关主题

期刊订阅